The mitochondria-targeted methylglyoxal sequestering compound, MitoGamide is cardioprotective in the diabetic heart

Tate, M., De Blasio, M. J., Prakoso, D., Deo, M., Higgins, G. C., Lindblom, R., Kiriazis, H., Baeza-Garza, C. D., Caldwell, S., Hartley, R. , Krieg, T., Murphy, M. P., Coughlan, M. T. and Ritchie, R. H. (2018) The mitochondria-targeted methylglyoxal sequestering compound, MitoGamide is cardioprotective in the diabetic heart. [Data Collection] (Unpublished)

Enlighten Publications URI: http://eprints.gla.ac.uk/id/eprint/197566
College / School: College of Science and Engineering > School of Chemistry
Date Deposited: 08 Jan 2020 12:32
Funder's Name: Wellcome Trust (WELLCOTR), Biotechnology and Biological Sciences Research Council (BBSRC)
URI: http://researchdata.gla.ac.uk/id/eprint/708

Available Files

Data

Read me

Repository Staff Only: Update this record

Tate, M., De Blasio, M. J., Prakoso, D., Deo, M., Higgins, G. C., Lindblom, R., Kiriazis, H., Baeza-Garza, C. D., Caldwell, S., Hartley, R. , Krieg, T., Murphy, M. P., Coughlan, M. T. and Ritchie, R. H. (2018); The mitochondria-targeted methylglyoxal sequestering compound, MitoGamide is cardioprotective in the diabetic heart

University of Glasgow

DOI: 10.5525/gla.researchdata.708

Retrieved: 2020-10-27

Downloads

Downloads per month over past year